Table 1

Summary of demographics along with clinical and dietary characteristics of subjects

SARS-CoV-2 negative; exposed control
(n=20)
SARS-CoV-2 positive
Asymptomatic
(n=4)
Mild
(n=6)
Moderate
(n=12)
Severe
(n=28)
Total
(n=50)
P value
Demographics
 USA resident20 (100.00%)4 (100.00%)6 (100.00%)12 (100.00%)28 (100.00%)50 (100.00%)ns
 Male7 (35.00%)3 (75.00%)2 (33.33%)5 (41.66%)14 (50.00%)24 (48.00%)0.5706
 Mean age ±SEM44.40±3.6247.50±9.4037.67±4.6550.58±5.9252.82±3.3350.00±2.500.5221
 Median age4850.5376055.553
 Race
 White17 (85.00%)3 (75.00%)5 (83.33%)9 (75.00%)27 (96.43%)44 (88.00%)0.3826
 Hispanic2 (10.00%)1 (25.00%)0 (0.00%)3 (25.00%)1 (3.57%)5 (10.00%)
 Black1 (5.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)0 (0.00%)
 Other0 (0.00%)0 (0.00%)1 (16.66%)0 (0.00%)0 (0.00%)1 (2.00%)
Clinical/dietary characteristics
 Severe COVID-19 comorbidities*12 (60.00%)3 (75.00%)3 (50.00%)10 (83.33%)16 (57.14%)32 (64.00%)0.5099
 Normal stool frequency20 (100.00%)4 (100.00%)6 (100.00%)10 (83.33%)24 (85.71%)44 (88.00%)0.2891
 Lack of appetite0 (0.00%)0 (0.00%)0 (0.00%)1 (8.33%)2 (7.14%)3 (6.00%)0.6663
 Omnivore diet19†(100.00%)4 (100.00%)6 (100.00%)12 (100.00%)28 (100.00%)50 (100.00%)ns
  • . Numbers in cells indicate number of subjects with percentage in categories, except for age and BMI, which indicate value. P values calculated via one-way ANOVA (age and BMI) or χ2 (others). Normal stool frequency is defined as absence of diarrhoea. Total refers to sum of SARS-CoV-2-positive subjects, and it is not used in statistics.

  • *Comorbid conditions indicative of severe SARS-CoV-2 infection (not including hypertension), based on Center for Disease Control (CDC) definitions.44

  • †Nineteen total subjects had data available for diet within exposed control.